Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 36.50B | 47.99B | 57.67B | 40.53B | 22.75B |
Gross Profit | 1.80B | 4.88B | 4.22B | 3.00B | 1.86B |
EBITDA | 2.32B | 4.87B | 3.60B | 2.48B | 1.35B |
Net Income | -257.00M | 2.56B | 1.29B | 731.00M | -414.36M |
Balance Sheet | |||||
Total Assets | 33.04B | 38.13B | 40.09B | 39.02B | 33.89B |
Cash, Cash Equivalents and Short-Term Investments | 1.59B | 1.32B | 1.61B | 1.30B | 2.53B |
Total Debt | 9.23B | 10.80B | 12.30B | 14.60B | 13.80B |
Total Liabilities | 16.20B | 20.90B | 25.43B | 25.66B | 21.27B |
Stockholders Equity | 16.84B | 17.23B | 14.66B | 13.36B | 12.62B |
Cash Flow | |||||
Free Cash Flow | -1.43B | 2.79B | 6.69B | -2.26B | -7.94B |
Operating Cash Flow | 264.00M | 3.43B | 8.24B | 145.00M | -90.14M |
Investing Cash Flow | -416.00M | -536.00M | -1.42B | -2.20B | -7.77B |
Financing Cash Flow | -2.27B | -1.50B | -2.34B | 794.00M | 8.69B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥8.37B | 9.76 | 2.05% | 13.02% | ― | ||
76 Outperform | ¥7.50B | 6.37 | 1.71% | 4.57% | -13.43% | ||
75 Outperform | ¥12.16B | 9.40 | 4.02% | -1.75% | -9.10% | ||
73 Outperform | ¥5.76B | 6.38 | 3.41% | 16.98% | 16.45% | ||
59 Neutral | ¥4.59B | 34.96 | 1.25% | 5.14% | 1.96% | ||
44 Neutral | C$980.66M | -6.79 | -13.68% | 1.76% | 17.37% | -32.98% | |
44 Neutral | ¥13.21B | 7.54 | -1.83% | 0.86% | -23.94% | -110.06% |